Sarah DALLEL
Praticien Hospitalier Universitaire
DALLEL
Sarah
Praticien Hospitalier Universitaire
Praticien Hospitalier
Publications
LXR pathway drives hormonal response intensity in polycystic ovary syndrome.
Published on 21 May 2025 in EMBO molecular medicine
Dallel S , Despalles M , Tore M , Renaud Y , Kocer A , Damon-Soubeyrand C , Pouchin P , Vachias C , Boutourlinsky K , Gonthier-Gueret C, De Haze A , Sanchez P , Pointud JC , Bouchareb E , Vialat M , Lagarde A , Gulunga C, Chaput L, Vega A , Brugnon F , Tauveron I , Trousson A , de Joussineau C , Degoul F , Morel L , Lobaccaro JM , Maqdasy S , Baron S
Liver X Receptors Enhance Epithelial to Mesenchymal Transition in Metastatic Prostate Cancer Cells.
Published on 06 Aug 2024 in Cancers , vol. 16
Bouchareb E , Dallel S , De Haze A , Damon-Soubeyrand C , Renaud Y , Baabdaty E , Vialat M , Fabre J , Pouchin P , De Joussineau C , Degoul F , Sanmukh S , Gendronneau J , Sanchez P , Gonthier-Gueret C , Trousson A , Morel L , Lobaccaro JM , Kocer A , Baron S
Persistent organic pollutants promote aggressiveness in prostate cancer.
Published on 01 Sep 2023 in Oncogene , vol. 42 - pp 2854-2867
Buñay J, Kossai M, Damon-Soubeyrant C, De Haze A , Saru JP , Trousson A , de Joussineau C , Bouchareb E , Kocer A , Vialat M , Dallel S , Degoul F , Bost F, Clavel S, Penault-Llorca F, Valli MP, Guy L, Matthews J, Renaud Y , Ittmann M, Jones J, Morel L , Lobaccaro JM , Baron S
MEN1 silencing aggravates tumorigenic potential of AR-independent prostate cancer cells through nuclear translocation and activation of JunD and β-catenin.
Published on 26 Aug 2021 in Journal of experimental & clinical cancer research : CR , vol. 40 - pp 270
Luo Y, Vlaeminck-Guillem V, Baron S , Dallel S , Zhang CX, Le Romancer M
Liver X Receptors: A Possible Link between Lipid Disorders and Female Infertility.
Published on 25 Jul 2018 in International journal of molecular sciences , vol. 19
Dallel S , Tauveron I , Brugnon F , Baron S , Lobaccaro JMA, Maqdasy S
